Clinical trial
Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3%
NCT01812525 is registered in ClinicalTrials.gov with Raphaelle Jaquet-Pilloud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3%
- Lead sponsor
- Raphaelle Jaquet-Pilloud
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- April 30, 2016
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
moderate to severe bronchiolitis